Can peptides 'retrain' the immune system in rheumatoid arthritis?

What did @shari_aesthetics actually say?

Honestly? Not much, medically speaking. The transcript is entirely motivational lyrics, not medical commentary. The actual health claims live in the caption, where @shari_aesthetics suggests RA is a problem of "mixed signals" rather than an immune system malfunction, and that peptides can "retrain your body to know friend from foe" while "easing inflammation and restoring comfort." That framing deserves real scrutiny.

The caption sets up a false binary: suppressing the immune system (bad, implied) versus retraining it (good, with peptides). This is a common wellness-influencer structure that borrows just enough immunology language to sound credible without actually engaging with what the science says. No specific peptide is named. No mechanism is explained. The viewer is left with a vibe, not information.

Does the science back this up?

Partially, in the broadest sense, and not in the way the caption implies. Some peptides have demonstrated anti-inflammatory properties in preclinical models, but "preclinical" is doing enormous work here. There is no peer-reviewed clinical trial establishing any peptide therapy as an effective treatment for rheumatoid arthritis in humans.

BPC-157, one of the more studied peptides in this category, has shown anti-inflammatory and tissue-repair effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design). GHK-Cu has demonstrated suppression of inflammatory cytokines in vitro (Pickart and Margolina, 2018, Symmetry). Selank has shown immunomodulatory properties in animal studies. None of these have completed randomized controlled trials in RA patients. The leap from "reduces inflammation in a rat's paw" to "retrains your immune system for autoimmune disease" is not a small one. It is a canyon.

What did they get wrong (or right)?

They got one thing directionally right: RA is not simply an on/off immune malfunction. It involves dysregulated signaling between T cells, B cells, and synovial tissue, which is genuinely complex (McInnes and Schett, 2011, New England Journal of Medicine). Framing it as "mixed signals" is reductive but not entirely inaccurate as a lay description.

What they got wrong is the implied solution. Approved RA treatments, including methotrexate, TNF inhibitors, and JAK inhibitors, actually do modulate immune signaling rather than simply suppress everything indiscriminately. The caption's framing that current medicine just "suppresses" while peptides "retrain" is a false contrast designed to make peptides sound superior to treatments with actual clinical evidence behind them. That is misleading, and in a population managing a serious progressive disease, misleading framing has real consequences. Delayed or abandoned evidence-based treatment in RA leads to irreversible joint damage.

What should you actually know?

If you have RA and you are watching TikTok videos about peptide therapy, here is the honest picture. Peptide research is a legitimate and active area of science. Some peptides show real biological activity in inflammatory pathways. Researchers are genuinely interested in whether compounds like BPC-157 or GHK-Cu might one day complement existing therapies. That is worth watching.

But "worth watching" and "use this instead of your rheumatologist's plan" are completely different statements. RA causes permanent joint destruction when undertreated. The ACR (American College of Rheumatology) guidelines are built on decades of trial data precisely because the stakes are high. No peptide has cleared that bar yet. If a telehealth provider or influencer is suggesting you "retrain" your immune system with peptides as a primary RA intervention, that is a red flag, not a breakthrough. Talk to a board-certified rheumatologist before changing anything about your treatment.